Greece Pharmaceuticals & Healthcare Report Q3 2018

Greece Pharmaceuticals & Healthcare Report Q3 2018

BMI View:

Multinational pharmaceutical firms will continue to face considerable challenges in Greece. The healthcare system as awhole will continue to struggle due to a lack of funding, resulting in high levels of debt. Medicine sales will remain on a lowly growthtrajectory, albeit now positive, due to restrictive public funding. Repressive government policy, including aggressive pricing, highclawback and rebates will continue to repress opportunities and create a high degree of risk. This will be exacerbated by theimplementation of the new health technology assessment medicine reimbursement scheme.

BMI Industry View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Pharmaceuticals Risk/Reward Index
Greece Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Genesis Pharma
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook